I have extensive experience as an expert witness, specializing in testimony and consulting for a wide range of infectious disease cases. I am committed to the highest professional standards, offering critical insights and rigorous analysis vital to legal proceedings involving infectious diseases.

Core Infectious Disease Expertise

• Antimicrobial Stewardship

• Bacterial and Fungal Infections

• COVID-19

• Endocarditis

• Osteomyelitis

• Pneumonia

• Sepsis

• Travel-Related Infections

• Waterborne Infections

Common Clinical Infections

• Cellulitis

• Necrotizing Fasciitis

• Orthopedic Infections

• Surgical Site Infections

• Urinary Tract Infections

Healthcare-Associated Infections and Settings

• Hospital-Acquired Infections

• Infections in Nursing Homes

• Nursing Homes, Hospitals, and Surgery Centers Litigation

• Workplace Settings Litigation

Prevention and Specialized Areas

• Outbreak Prevention and Management

• Trsvel-Related Infections

• Mass Tort Cases

I provide expert consulting services to hospitals, ambulatory surgery centers, long-term care facilities, dialysis centers, and other healthcare organizations dedicated to protecting patients, staff, and visitors from preventable infections.

Effective infection prevention and control (IPC) programs are essential for reducing healthcare-associated infections (HAIs), ensuring regulatory compliance, and fostering a culture of safety. My tailored consulting services help institutions build, strengthen, and sustain evidence-based IPC programs that align with CDC, CMS, Joint Commission, and state health department requirements, as well as guidelines from SHEA and APIC.

Key Services Include:

• Program Assessment and Gap Analysis: Comprehensive on-site or remote evaluation of existing IPC policies, practices, surveillance systems, and risk assessments to identify strengths and opportunities for improvement.

• Policy and Procedure Development: Creation or revision of evidence-based protocols for hand hygiene, isolation precautions, environmental cleaning, device-associated infection prevention, and antimicrobial-resistant organism management.

• Surveillance and Data Analysis: Design and implementation of HAI surveillance systems, including NHSN reporting, outbreak detection, and actionable data dashboards to track trends and measure intervention impact.

• Outbreak Investigation and Management: Rapid response support for investigating and controlling outbreaks of multidrug-resistant organisms, Clostridioides difficile, viral respiratory pathogens, and other transmissible infections.

• Staff Education and Competency Training: Customized training programs for frontline staff, physicians, environmental services, and leadership on best practices, regulatory updates, and sustained behavior change.

• Construction and Renovation Risk Assessments: Infection control risk assessments (ICRAs) for facility projects, including guidance on air handling, water management, and barrier measures to prevent construction-related infections (e.g., Aspergillus, Legionella).

• Water Management Programs: Development and oversight of Legionella and waterborne pathogen prevention plans in compliance with CMS and ASHRAE standards.

• Regulatory Preparation and Survey Support: Mock surveys, corrective action planning, and on-site assistance during Joint Commission, CMS, or state surveys to ensure readiness and compliance.

• Tele-Infection Prevention Services: Remote consulting and virtual rounding options for rural or resource-limited facilities needing ongoing expert guidance.

By partnering with me, your organization can achieve lower HAI rates, improved patient safety outcomes, enhanced staff confidence, regulatory compliance, and substantial cost savings through reduced infections and avoided penalties.

I offer specialized consulting services to hospitals, long-term care facilities, and healthcare systems committed to combating antimicrobial resistance and improving patient outcomes.

Antimicrobial stewardship involves coordinated strategies to ensure the appropriate use of antimicrobials—selecting the right drug, dose, duration, and route—to maximize clinical effectiveness while minimizing toxicity, resistance, and unnecessary costs. My services are designed to help your institution implement or enhance a robust antimicrobial stewardship program (ASP) in alignment with CDC Core Elements, Joint Commission standards, and IDSA/SHEA guidelines.

Key Services Include:

• Program Development and Leadership: Guidance in establishing or refining ASPs, including appointing multidisciplinary teams, policy development, and integration with infection prevention efforts.

• Prospective Audit and Feedback: Daily review of antimicrobial prescriptions with personalized, evidence-based recommendations to prescribers for de-escalation, narrowing spectrum, or discontinuation.

• Pre-Authorization Support: Expertise in restricting high-risk or broad-spectrum agents, ensuring timely approvals while promoting judicious use.

• Education and Training: Tailored sessions for physicians, pharmacists, nurses, and staff on best practices, local resistance patterns (antibiograms), and guideline adherence.

• Data Analysis and Reporting: Tracking antimicrobial use, resistance trends, and outcomes to demonstrate program impact, cost savings, and compliance.

• Tele-Stewardship Options: Remote consulting for rural or resource-limited facilities, providing real-time expertise without on-site presence.

• Outbreak and Special Focus Support: Assistance with managing resistant organisms, C. difficile reduction, and stewardship in high-risk areas like ICUs or surgical services.

By partnering with me, your facility can achieve improved patient safety, reduced antimicrobial resistance, lower infection rates (e.g., fewer healthcare-associated infections), and significant cost savings—often through decreased broad-spectrum antibiotic use and shorter therapy durations.

I offer specialized consulting services to public health departments, hospitals, schools, workplaces, long-term care facilities, correctional institutions, and other organizations facing infectious disease challenges.

My expertise bridges clinical infectious diseases with population-level epidemiology, enabling comprehensive assessment, investigation, and control of infectious threats. I provide evidence-based guidance aligned with CDC, WHO, state health department protocols, and professional society recommendations to help clients prevent, detect, and respond effectively to infectious disease events.

Key Services Include:

• Outbreak Investigation and Management: Rapid deployment for on-site or remote support in investigating clusters and outbreaks of respiratory viruses, gastrointestinal illnesses, vaccine-preventable diseases, healthcare-associated infections, and emerging pathogens.

• Contact Tracing Program Design and Implementation: Development of scalable contact tracing systems, including training for tracers, integration of digital tools, case interview protocols, and monitoring/quarantine guidance in compliance with privacy regulations.

• Epidemiological Analysis and Surveillance: Design and enhancement of surveillance systems, data analysis (including epi curves, attack rates, and risk factor identification), and interpretation of public health data to inform decision-making.

• Risk Assessment and Modeling: Quantitative and qualitative risk assessments for infectious disease introduction or spread in specific settings, with scenario-based planning and basic transmission modeling when needed.

• Policy and Protocol Development: Creation of evidence-based guidelines for isolation, quarantine, testing strategies, vaccination programs, and return-to-work/school policies.

• Training and Capacity Building: Customized education for public health staff, healthcare workers, administrators, and community stakeholders on epidemiology principles, outbreak response, contact tracing techniques, and infection prevention.

• Expert Support for Emerging Threats: Guidance on novel or re-emerging pathogens, pandemic preparedness planning, and integration of lessons learned from events such as COVID-19, mpox, or influenza pandemics.

• Legal and Public Communication Support: Assistance with clear, accurate risk communication to stakeholders, media, and the public, as well as epidemiologic support for litigation or regulatory inquiries related to outbreaks.